Spironolactone

Denton Pharma, Inc. dba Northwind Pharmaceuticals🇺🇸 United States

FDA Page

Effective Date: Jul 30, 2020
Approval ID: ac9afaff-ef80-0f51-e053-2995a90a7207
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE (spironolactone) tablets for oral use Initial U.S. Approval: 1960

Quick Stats

Total Products1

Labelers2

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.